Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00034925.xml
Download PDF
Hamostaseologie 2026; 46(01): 044-052
DOI: 10.1055/a-2755-7600
DOI: 10.1055/a-2755-7600
Review Article
The Role of Platelets Beyond Hemostasis
Authors
Funding F.R. is supported by a grant of the ReALity initiative of the state of Rhineland Palatinate. C.D. is supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – Project-ID (318346496–SFB 1292) and the DFG Emmy Noether Program (DE 2654/2–1) as well by the Federal Ministry of Research, Technology and Space (BMFTR), grant number 03ZU1202GA.
Abstract
Platelets, small anucleate cells derived from megakaryocytes, are key drivers of hemostasis and thrombosis. There is accumulating evidence, however, that platelets play roles beyond thrombosis and hemostasis, especially in inflammation, infection, and tissue regeneration. They can recruit, stimulate, and modulate immune cells by direct interaction or via the release of soluble factors. During inflammation, platelets maintain vascular integrity in the lung, skin, and brain through interactions of their GPVI, CLEC-2, and GPIb receptors as well as factors released from α-granules and dense granules. They cooperate with monocytes and macrophages to fight bacteria in the bloodstream and in the liver where they accumulate on Kupffer cell–bacteria complexes to support pathogen destruction. Upon liver damage, platelets adhere to the liver sinusoids and release bioactive molecules like serotonin and fibrinogen to support reparative processes. Here, we provide a review of some of the multiple roles of platelets beyond their classical role in hemostasis.
Keywords
platelets - hemostasis - thrombosis - granules - liver - infection - inflammation bleeding - Kupffer cellsPublication History
Received: 30 October 2025
Accepted: 23 November 2025
Article published online:
17 February 2026
© 2026. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Maxwell MJ, Westein E, Nesbitt WS, Giuliano S, Dopheide SM, Jackson SP. Identification of a 2-stage platelet aggregation process mediating shear-dependent thrombus formation. Blood 2007; 109 (02) 566-576
- 2 Weiss HJ, Turitto VT, Baumgartner HR. Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate-dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome. J Lab Clin Med 1978; 92 (05) 750-764
- 3 Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 1998; 67: 395-424
- 4 Schneider SW, Nuschele S, Wixforth A. et al. Shear-induced unfolding triggers adhesion of von Willebrand factor fibers. Proc Natl Acad Sci U S A 2007; 104 (19) 7899-7903
- 5 Arya M, López JA, Romo GM. et al. Glycoprotein Ib-IX-mediated activation of integrin alpha(IIb)beta(3): effects of receptor clustering and von Willebrand factor adhesion. J Thromb Haemost 2003; 1 (06) 1150-1157
- 6 Delaney MK, Liu J, Zheng Y, Berndt MC, Du X. The role of Rac1 in glycoprotein Ib-IX-mediated signal transduction and integrin activation. Arterioscler Thromb Vasc Biol 2012; 32 (11) 2761-2768
- 7 Kasirer-Friede A, Cozzi MR, Mazzucato M, De Marco L, Ruggeri ZM, Shattil SJ. Signaling through GP Ib-IX-V activates alpha IIb beta 3 independently of other receptors. Blood 2004; 103 (09) 3403-3411
- 8 Jackson SP, Nesbitt WS, Westein E. Dynamics of platelet thrombus formation. J Thromb Haemost 2009; 7 (Suppl. 01) 17-20
- 9 Folie BJ, McIntire LV. Mathematical analysis of mural thrombogenesis. Concentration profiles of platelet-activating agents and effects of viscous shear flow. Biophys J 1989; 56 (06) 1121-1141
- 10 Sharda A, Flaumenhaft R. The life cycle of platelet granules. F1000 Res 2018; 7: 236
- 11 Koupenova M, Clancy L, Corkrey HA, Freedman JE. Circulating platelets as mediators of immunity, inflammation, and thrombosis. Circ Res 2018; 122 (02) 337-351
- 12 Kerris EWJ, Hoptay C, Calderon T, Freishtat RJ. Platelets and platelet extracellular vesicles in hemostasis and sepsis. J Investig Med 2020; 68 (04) 813-820
- 13 Blair P, Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 2009; 23 (04) 177-189
- 14 Sims MC, Mayer L, Collins JH. et al; NIHR BioResource. Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome. Blood 2020; 136 (17) 1956-1967
- 15 Gunay-Aygun M, Falik-Zaccai TC, Vilboux T. et al. NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules. Nat Genet 2011; 43 (08) 732-734
- 16 Deppermann C, Cherpokova D, Nurden P. et al. Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice. J Clin Invest 2013; 123 (08) 3331-3342
- 17 Lambert MP, Gernsheimer TB. Clinical updates in adult immune thrombocytopenia. Blood 2017; 129 (21) 2829-2835
- 18 Cohen YC, Djulbegovic B, Shamai-Lubovitz O, Mozes B. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med 2000; 160 (11) 1630-1638
- 19 Neunert CE, Buchanan GR, Imbach P. et al; Intercontinental Cooperative ITP Study Group Registry II Participants. Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS). Blood 2013; 121 (22) 4457-4462
- 20 Arnold DM. Platelet count or bleeding as the outcome in ITP trials?. Am J Hematol 2012; 87 (10) 945-946
- 21 Goerge T, Ho-Tin-Noe B, Carbo C. et al. Inflammation induces hemorrhage in thrombocytopenia. Blood 2008; 111 (10) 4958-4964
- 22 Boulaftali Y, Hess PR, Getz TM. et al. Platelet ITAM signaling is critical for vascular integrity in inflammation. J Clin Invest 2013; 123 (02) 908-916
- 23 Rayes J, Jadoui S, Lax S. et al. The contribution of platelet glycoprotein receptors to inflammatory bleeding prevention is stimulus and organ dependent. Haematologica 2018; 103 (06) e256-e258
- 24 Kaiser R, Anjum A, Kammerer L. et al. Mechanosensing via a GpIIb/Src/14-3-3ζ axis critically regulates platelet migration in vascular inflammation. Blood 2023; 141 (24) 2973-2992
- 25 Stegner D, Deppermann C, Kraft P. et al. Munc13-4-mediated secretion is essential for infarct progression but not intracranial hemostasis in acute stroke. J Thromb Haemost 2013; 11 (07) 1430-1433
- 26 Ren Q, Wimmer C, Chicka MC. et al. Munc13-4 is a limiting factor in the pathway required for platelet granule release and hemostasis. Blood 2010; 116 (06) 869-877
- 27 Kahr WH, Lo RW, Li L. et al. Abnormal megakaryocyte development and platelet function in Nbeal2(-/-) mice. Blood 2013; 122 (19) 3349-3358
- 28 Savage JS, Williams CM, Konopatskaya O, Hers I, Harper MT, Poole AW. Munc13-4 is critical for thrombosis through regulating release of ADP from platelets. J Thromb Haemost 2013; 11 (04) 771-775
- 29 Deppermann C, Kraft P, Volz J. et al. Platelet secretion is crucial to prevent bleeding in the ischemic brain but not in the inflamed skin or lung in mice. Blood 2017; 129 (12) 1702-1706
- 30 Kleinschnitz C, Pozgajova M, Pham M, Bendszus M, Nieswandt B, Stoll G. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Circulation 2007; 115 (17) 2323-2330
- 31 Ho-Tin-Noé B, Goerge T, Cifuni SM, Duerschmied D, Wagner DD. Platelet granule secretion continuously prevents intratumor hemorrhage. Cancer Res 2008; 68 (16) 6851-6858
- 32 Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Dynamics of leukocyte-platelet adhesion in whole blood. Blood 1991; 78 (07) 1730-1737
- 33 Moore KL, Stults NL, Diaz S. et al. Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells. J Cell Biol 1992; 118 (02) 445-456
- 34 Neumann FJ, Zohlnhöfer D, Fakhoury L, Ott I, Gawaz M, Schömig A. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J Am Coll Cardiol 1999; 34 (05) 1420-1426
- 35 Simon DI, Chen Z, Xu H. et al. Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 2000; 192 (02) 193-204
- 36 Lindmark E, Tenno T, Siegbahn A. Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arterioscler Thromb Vasc Biol 2000; 20 (10) 2322-2328
- 37 Bennett JS. Structure and function of the platelet integrin alphaIIbbeta3. J Clin Invest 2005; 115 (12) 3363-3369
- 38 Gawaz MP, Loftus JC, Bajt ML, Frojmovic MM, Plow EF, Ginsberg MH. Ligand bridging mediates integrin alpha IIb beta 3 (platelet GPIIB-IIIA) dependent homotypic and heterotypic cell-cell interactions. J Clin Invest 1991; 88 (04) 1128-1134
- 39 Flick MJ, Du X, Witte DP. et al. Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest 2004; 113 (11) 1596-1606
- 40 von Hundelshausen P, Weber KSC, Huo Y. et al. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 2001; 103 (13) 1772-1777
- 41 Pervushina O, Scheuerer B, Reiling N. et al. Platelet factor 4/CXCL4 induces phagocytosis and the generation of reactive oxygen metabolites in mononuclear phagocytes independently of Gi protein activation or intracellular calcium transients. J Immunol 2004; 173 (03) 2060-2067
- 42 Sarma J, Laan CA, Alam S, Jha A, Fox KAA, Dransfield I. Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation 2002; 105 (18) 2166-2171
- 43 Furman MI, Benoit SE, Barnard MR. et al. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 1998; 31 (02) 352-358
- 44 Joseph JE, Harrison P, Mackie IJ, Isenberg DA, Machin SJ. Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol 2001; 115 (02) 451-459
- 45 Tunjungputri RN, Van Der Ven AJ, Schonsberg A. et al. Reduced platelet hyperreactivity and platelet-monocyte aggregation in HIV-infected individuals receiving a raltegravir-based regimen. AIDS 2014; 28 (14) 2091-2096
- 46 Tsai J-J, Jen Y-H, Chang J-S, Hsiao H-M, Noisakran S, Perng GC. Frequency alterations in key innate immune cell components in the peripheral blood of dengue patients detected by FACS analysis. J Innate Immun 2011; 3 (05) 530-540
- 47 Hottz ED, Medeiros-de-Moraes IM, Vieira-de-Abreu A. et al. Platelet activation and apoptosis modulate monocyte inflammatory responses in dengue. J Immunol 2014; 193 (04) 1864-1872
- 48 Scull CM, Hays WD, Fischer TH. Macrophage pro-inflammatory cytokine secretion is enhanced following interaction with autologous platelets. J Inflamm (Lond) 2010; 7: 53
- 49 Rondina MT, Carlisle M, Fraughton T. et al. Platelet-monocyte aggregate formation and mortality risk in older patients with severe sepsis and septic shock. J Gerontol A Biol Sci Med Sci 2015; 70 (02) 225-231
- 50 Xiang B, Zhang G, Guo L. et al. Platelets protect from septic shock by inhibiting macrophage-dependent inflammation via the cyclooxygenase 1 signalling pathway. Nat Commun 2013; 4 (01) 2657
- 51 de Stoppelaar SF, van 't Veer C, Claushuis TAM, Albersen BJA, Roelofs JJTH, van der Poll T. Thrombocytopenia impairs host defense in gram-negative pneumonia-derived sepsis in mice. Blood 2014; 124 (25) 3781-3790
- 52 Ali RA, Wuescher LM, Dona KR, Worth RG. Platelets mediate host defense against Staphylococcus aureus through direct bactericidal activity and by enhancing macrophage activities. J Immunol 2017; 198 (01) 344-351
- 53 Carestia A, Mena HA, Olexen CM. et al. Platelets promote macrophage polarization toward pro-inflammatory phenotype and increase survival of septic mice. Cell Rep 2019; 28 (04) 896-908.e5
- 54 Nusse Y, Kubes P. Liver macrophages: development, dynamics, and functions. Cell Mol Immunol 2025; 22 (10) 1178-1189
- 55 Lee W-Y, Moriarty TJ, Wong CHY. et al. An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells. Nat Immunol 2010; 11 (04) 295-302
- 56 Deppermann C, Peiseler M, Zindel J. et al. Tacrolimus impairs Kupffer cell capacity to control bacteremia: why transplant recipients are susceptible to infection. Hepatology 2021; 73 (05) 1967-1984
- 57 Zeng Z, Surewaard BG, Wong CH, Geoghegan JA, Jenne CN, Kubes P. CRIg functions as a macrophage pattern recognition receptor to directly bind and capture blood-borne Gram-positive bacteria. Cell Host Microbe 2016; 20 (01) 99-106
- 58 Surewaard BGJ, Deniset JF, Zemp FJ. et al. Identification and treatment of the Staphylococcus aureus reservoir in vivo. J Exp Med 2016; 213 (07) 1141-1151
- 59 Wong CHY, Jenne CN, Petri B, Chrobok NL, Kubes P. Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat Immunol 2013; 14 (08) 785-792
- 60 Surewaard BGJ, Thanabalasuriar A, Zeng Z. et al. α-Toxin induces platelet aggregation and liver injury during Staphylococcus aureus sepsis. Cell Host Microbe 2018; 24 (02) 271-284.e3
- 61 Carestia A, Davis RP, Grosjean H, Lau MW, Jenne CN. Acetylsalicylic acid inhibits intravascular coagulation during Staphylococcus aureus-induced sepsis in mice. Blood 2020; 135 (15) 1281-1286
- 62 Rinella ME, Lazarus JV, Ratziu V. et al; NAFLD Nomenclature consensus group. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 2023; 78 (06) 1966-1986
- 63 Boccatonda A, Del Cane L, Marola L. et al. Platelet, antiplatelet therapy and metabolic dysfunction-associated steatotic liver disease: a narrative review. Life (Basel) 2024; 14 (04) 473
- 64 Harm T, Rohlfing AK, Henes JK. et al. Reduced platelet aggregation and plasma cytokine levels mitigate progressive metabolic dysfunction-associated steatotic liver disease (MASLD). J Inflamm Res 2025; 18: 11385-11400
- 65 Castelli M, Zoncapè M, Meneguzzi A. et al. Platelet functional profile is altered in metabolic dysfunction-associated steatotic liver disease. Liver Int 2025; 45 (08) e70231
- 66 Miele L, Alberelli MA, Martini M. et al. Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets. Transl Res 2021; 231: 24-38
- 67 Malehmir M, Pfister D, Gallage S. et al. Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer. Nat Med 2019; 25 (04) 641-655
- 68 Li D, Xie P, Zhao S. et al. Hepatocytes derived increased SAA1 promotes intrahepatic platelet aggregation and aggravates liver inflammation in NAFLD. Biochem Biophys Res Commun 2021; 555: 54-60
- 69 Kirschbaum M, Karimian G, Adelmeijer J, Giepmans BN, Porte RJ, Lisman T. Horizontal RNA transfer mediates platelet-induced hepatocyte proliferation. Blood 2015; 126 (06) 798-806
- 70 Risitano A, Beaulieu LM, Vitseva O, Freedman JE. Platelets and platelet-like particles mediate intercellular RNA transfer. Blood 2012; 119 (26) 6288-6295
- 71 Balaphas A, Meyer J, Sadoul K. et al. Platelets and platelet-derived extracellular vesicles in liver physiology and disease. Hepatol Commun 2019; 3 (07) 855-866
- 72 Karakas D, Li J, Ma W. et al. Kupffer cells are essential for platelet-mediated thrombopoietin generation in the liver. Proc Natl Acad Sci U S A 2025; 122 (38) e2517319122
- 73 Beier JI, Guo L, Ritzenthaler JD, Joshi-Barve S, Roman J, Arteel GE. Fibrin-mediated integrin signaling plays a critical role in hepatic regeneration after partial hepatectomy in mice. Ann Hepatol 2016; 15 (05) 762-772
- 74 Groeneveld D, Pereyra D, Veldhuis Z. et al. Intrahepatic fibrin(ogen) deposition drives liver regeneration after partial hepatectomy in mice and humans. Blood 2019; 133 (11) 1245-1256
- 75 Kirschbaum M, Jenne CN, Veldhuis ZJ. et al. Transient von Willebrand factor-mediated platelet influx stimulates liver regeneration after partial hepatectomy in mice. Liver Int 2017; 37 (11) 1731-1737
- 76 Kono H, Fujii H, Suzuki-Inoue K. et al. The platelet-activating receptor C-type lectin receptor-2 plays an essential role in liver regeneration after partial hepatectomy in mice. J Thromb Haemost 2017; 15 (05) 998-1008
- 77 Abu Rmilah A, Zhou W, Nelson E, Lin L, Amiot B, Nyberg SL. Understanding the marvels behind liver regeneration. Wiley Interdiscip Rev Dev Biol 2019; 8 (03) e340
- 78 Lesurtel M, Clavien PA. Platelet-derived serotonin: translational implications for liver regeneration. Hepatology 2014; 60 (01) 30-33
- 79 Kawasaki T, Murata S, Takahashi K. et al. Activation of human liver sinusoidal endothelial cell by human platelets induces hepatocyte proliferation. J Hepatol 2010; 53 (04) 648-654
- 80 Reusswig F, Fazel Modares N, Brechtenkamp M. et al. Efficiently restored thrombopoietin production by Ashwell-Morell receptor and IL-6R induced Janus kinase 2/signal transducer and activator of transcription signaling early after partial hepatectomy. Hepatology 2021; 74 (01) 411-427
- 81 Gowert NS, Klier M, Reich M. et al. Defective platelet activation and bleeding complications upon cholestasis in mice. Cell Physiol Biochem 2017; 41 (06) 2133-2149
- 82 Takahashi K, Murata S, Ohkohchi N. Novel therapy for liver regeneration by increasing the number of platelets. Surg Today 2013; 43 (10) 1081-1087
- 83 Zhang Q, Raoof M, Chen Y. et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010; 464 (7285) 104-107
- 84 Arriazu E, Ruiz de Galarreta M, Cubero FJ. et al. Extracellular matrix and liver disease. Antioxid Redox Signal 2014; 21 (07) 1078-1097
- 85 Kabra H, Walimbe T, Stuart K. et al. Localized inhibition of platelets and platelet derived growth factor by a matrix targeted glycan mimetic significantly attenuates liver fibrosis. Biomaterials 2021; 269: 120538
- 86 Matsuo R, Ohkohchi N, Murata S. et al. Platelets strongly induce hepatocyte proliferation with IGF-1 and HGF in vitro. J Surg Res 2008; 145 (02) 279-286
- 87 Fazel Modares N, Polz R, Haghighi F. et al. IL-6 trans-signaling controls liver regeneration after partial hepatectomy. Hepatology 2019; 70 (06) 2075-2091
- 88 Kikuchi A, Pradhan-Sundd T, Singh S, Nagarajan S, Loizos N, Monga SP. Platelet-derived growth factor receptor α contributes to human hepatic stellate cell proliferation and migration. Am J Pathol 2017; 187 (10) 2273-2287
- 89 Mussbacher M, Brunnthaler L, Panhuber A, Starlinger P, Assinger A. Till death do us part—the multifaceted role of platelets in liver diseases. Int J Mol Sci 2021; 22 (06) 3113
- 90 Chauhan A, Adams DH, Watson SP, Lalor PF. Platelets: no longer bystanders in liver disease. Hepatology 2016; 64 (05) 1774-1784
- 91 Slaba I, Wang J, Kolaczkowska E, McDonald B, Lee WY, Kubes P. Imaging the dynamic platelet-neutrophil response in sterile liver injury and repair in mice. Hepatology 2015; 62 (05) 1593-1605
- 92 McDonald B, Pittman K, Menezes GB. et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 2010; 330 (6002) 362-366
- 93 López ML, Uribe-Cruz C, Osvaldt A. et al. Encapsulated platelets modulate Kupffer cell activation and reduce oxidative stress in a model of acute liver failure. Liver Transpl 2016; 22 (11) 1562-1572
- 94 Balaphas A, Meyer J, Perozzo R. et al. Platelet transforming growth factor-β1 induces liver sinusoidal endothelial cells to secrete interleukin-6. Cells 2020; 9 (05) 1311
- 95 Akerman P, Cote P, Yang SQ. et al. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am J Physiol 1992; 263 (4 Pt 1): G579-G585
- 96 Murata S, Matsuo R, Ikeda O. et al. Platelets promote liver regeneration under conditions of Kupffer cell depletion after hepatectomy in mice. World J Surg 2008; 32 (06) 1088-1096
- 97 Blakytny R, Ludlow A, Martin GE. et al. Latent TGF-beta1 activation by platelets. J Cell Physiol 2004; 199 (01) 67-76
- 98 Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 1983; 258 (11) 7155-7160
- 99 Dooley S, ten Dijke P. TGF-β in progression of liver disease. Cell Tissue Res 2012; 347 (01) 245-256
- 100 Frick J, Frobert A, Quintela Pousa AM. et al. Evidence for platelet-derived transforming growth factor β1 as an early inducer of liver regeneration after hepatectomy in mice. FASEB J 2024; 38 (17) e70039
- 101 Wang XL, Yang M, Wang Y. Roles of transforming growth factor-β signaling in liver disease. World J Hepatol 2024; 16 (07) 973-979
- 102 Orme ME, Bentley R, Marcella S. et al. Systematic review with meta-analysis: efficacy and safety of lusutrombopag for severe thrombocytopenia in patients with chronic liver disease undergoing invasive procedures. Adv Ther 2022; 39 (09) 4169-4188
- 103 Maruyama T, Murata S, Takahashi K. et al. Platelet transfusion improves liver function in patients with chronic liver disease and cirrhosis. Tohoku J Exp Med 2013; 229 (03) 213-220
- 104 Almeida TML, Freitas FGR, Figueiredo RC. et al; BRICNET. Acetylsalicylic acid treatment in patients with sepsis and septic shock: a phase 2, placebo-controlled, randomized clinical trial. Crit Care Med 2025; 53 (02) e269-e281
- 105 Caffrey AR, Appaneal HJ, LaPlante KL. et al. Impact of clopidogrel on clinical outcomes in patients with Staphylococcus aureus bacteremia: a national retrospective cohort study. Antimicrob Agents Chemother 2022; 66 (06) e0211721
- 106 Simon TG, Wilechansky RM, Stoyanova S. et al. Aspirin for metabolic dysfunction-associated steatotic liver disease without cirrhosis: a randomized clinical trial. JAMA 2024; 331 (11) 920-929